Breaking News Instant updates and real-time market news.

CELG

Celgene

$104.27

-0.26 (-0.25%)

07:34
10/04/16
10/04
07:34
10/04/16
07:34

Celgene reports acceptance of late-breaking GED-0301 CD-001 abstract at UEGW

Celgene Corporation announced that the data from a randomized, double-blind, multicenter, exploratory phase Ib study evaluating the effects of oral GED-0301 on both endoscopic and clinical outcomes in patients with active Crohn's disease were accepted as a late breaking abstract at the United European Gastroenterology Week. The data are to be presented on October 18, 2016 at 6:27 a.m. ET.

  • 07

    Oct

  • 27

    Oct

  • 06

    Nov

CELG Celgene
$104.27

-0.26 (-0.25%)

09/12/16
PIPR
09/12/16
NO CHANGE
PIPR
Overweight
Piper's Schimmer says Celgene GED-0301 data 'vague'
Piper Jaffray analyst Joshua Schimmer says he remains skeptical on the profile of Celgene's GED-0301 for Crohn's disease. This morning's "vague press release doesn't help despite the company's expressed confidence," Schimmer tells investors in a research note. He notes that while GED-0301 is not a relevant driver of his investment thesis, the drug is important to sentiment overall. The analyst reiterates an Overweight rating on Celgene.
09/16/16
RBCM
09/16/16
NO CHANGE
RBCM
Celgene shares can advance, says RBC Capital
RBC Capital analyst Michael Yee says that Celgene's stock "can grind higher" as investors eventually understand that the company's GED-0301 drug could potentially generate $1B in revenue. Yee says endoscopy data the company is expected to present next month on GED-0301 "isn't likely to be impressive." However, he thinks the data will "suggest that the drug is working," and he says that investor expectations are low, while the recent pullback in the shares has created an attractive entry point.
09/29/16
SBSH
09/29/16
NO CHANGE
Target $127
SBSH
Buy
Citi ups Celgene target to $127 on luspatercept opportunity
Citi analyst Robyn Karnauskas raised her price target for Celgene (CELG) to $127 from $124 citing greater confidence in the company's myelodysplastic syndrome and beta thalassemia opportunities. After initiating coverage of Celgene partner Acceleron (XLRN) with a Neutral rating, Karnauskas now sees adjusted peak sales for these indications of $1.7B versus $825M previously. Investors are missing the "not-so-distant catalyst" as Phase 3 luspatercept data in these indications could come in late 2017/early 2018, the analyst tells investors in a research note. She keeps a Buy rating on shares of Celgene.
09/30/16
PIPR
09/30/16
NO CHANGE
Target $25
PIPR
Overweight
Piper's Schimmer found Nektar validation at Celgene event
Piper Jaffray analyst Joshua Schimmer says Celgene's (CELG) analyst event provided "another indirect validation" of Nektar Therapeutics' (NKTR) oncology approach. Celgene surprisingly implicated IL-2 as one of the primary mechanisms of Revlimid, Schimmer tells investors in a research note. He views the development as supporting his "enthusiastic outlook" for NKTR-214, the company's long-acting IL-2 targeting Teffector cells. The analyst reiterates an Overweight rating on Nektar with a $25 price target.

TODAY'S FREE FLY STORIES

CE

Celanese

$80.91

0.26 (0.32%)

13:19
12/07/16
12/07
13:19
12/07/16
13:19
Conference/Events
Celanese participates in a conference call with Goldman »

Goldman hosts a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Dec

TSRA

Tessera

$40.35

0.55 (1.38%)

13:17
12/07/16
12/07
13:17
12/07/16
13:17
Conference/Events
Tessera management to meet with Sidoti »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Dec

$NYE

NYSE Market Internals

13:16
12/07/16
12/07
13:16
12/07/16
13:16
Technical Analysis
NYSE market internals summary »

Breadth is bullish across…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

13:16
12/07/16
12/07
13:16
12/07/16
13:16
Technical Analysis
NASDAQ market internals summary »

Volume is extremely heavy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AAPL

Apple

$109.95

0.84 (0.77%)

, FOX

21st Century Fox

$27.37

-0.16 (-0.58%)

13:12
12/07/16
12/07
13:12
12/07/16
13:12
Periodicals
Apple in talks with studios about early release movie rentals, Bloomberg says »

Apple (AAPL) is in talks…

AAPL

Apple

$109.95

0.84 (0.77%)

FOX

21st Century Fox

$27.37

-0.16 (-0.58%)

FOXA

21st Century Fox

$27.50

-0.06 (-0.22%)

TWX

Time Warner

CMCSA

Comcast

$68.70

0.02 (0.03%)

CMCSK

Comcast

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

  • 07

    Dec

  • 13

    Mar

ALR

Alere

$39.70

-0.16 (-0.40%)

13:11
12/07/16
12/07
13:11
12/07/16
13:11
Hot Stocks
Breaking Hot Stocks news story on Alere »

Alere down 10% after…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

QCOM

Qualcomm

$67.45

1.09 (1.64%)

13:10
12/07/16
12/07
13:10
12/07/16
13:10
Hot Stocks
Qualcomm begins commercial sampling of 10nm server processor »

Qualcomm Incorporated,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Mar

ALR

Alere

$39.70

-0.16 (-0.40%)

13:10
12/07/16
12/07
13:10
12/07/16
13:10
Hot Stocks
Breaking Hot Stocks news story on Alere 

Alere trading resumes

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RIG

Transocean

$14.48

0.23 (1.61%)

13:10
12/07/16
12/07
13:10
12/07/16
13:10
Options
Defensive option play opened in Transocean »

Defensive option play…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

X

U.S. Steel

$38.08

2.13 (5.92%)

13:09
12/07/16
12/07
13:09
12/07/16
13:09
Hot Stocks
Breaking Hot Stocks news story on U.S. Steel »

U.S. Steel CEO says…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

X

U.S. Steel

$38.09

2.1375 (5.95%)

13:07
12/07/16
12/07
13:07
12/07/16
13:07
Hot Stocks
Breaking Hot Stocks news story on U.S. Steel »

U.S. Steel CEO says…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CRDS

Crossroads Systems

$5.45

1.12 (25.87%)

13:07
12/07/16
12/07
13:07
12/07/16
13:07
Hot Stocks
Breaking Hot Stocks news story on Crossroads Systems »

Lloyd Miller III reports…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

X

U.S. Steel

$37.99

2.04 (5.67%)

13:06
12/07/16
12/07
13:06
12/07/16
13:06
Hot Stocks
U.S. Steel CEO says prior administrations didn't understand trade laws »

The U.S. Steel CEO is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AJG

Arthur J. Gallagher

$50.18

0.36 (0.72%)

13:05
12/07/16
12/07
13:05
12/07/16
13:05
Hot Stocks
Arthur J. Gallagher & Co. renews Chip Ganassi Racing partnership for 2017 »

Arthur J. Gallagher &…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

13:05
12/07/16
12/07
13:05
12/07/16
13:05
General news
Treasury Action: it's never too early to be thinking about year-end »

Treasury Action:…

RDS.A

Royal Dutch Shell

$52.59

0.219 (0.42%)

, RDS.B

Royal Dutch Shell

$55.96

0.24 (0.43%)

13:03
12/07/16
12/07
13:03
12/07/16
13:03
Periodicals
Shell signs provisional oil and gasfield agreement with Iran, FT says »

Royal Dutch Shell has…

RDS.A

Royal Dutch Shell

$52.59

0.219 (0.42%)

RDS.B

Royal Dutch Shell

$55.96

0.24 (0.43%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ALR

Alere

$39.70

-0.16 (-0.40%)

, ABT

Abbott

$38.02

-0.4 (-1.04%)

13:00
12/07/16
12/07
13:00
12/07/16
13:00
Hot Stocks
Alere issues statement regarding Abbott lawsuit »

Alere (ALR) issued the…

ALR

Alere

$39.70

-0.16 (-0.40%)

ABT

Abbott

$38.02

-0.4 (-1.04%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

PI

Impinj

$29.58

2.1 (7.64%)

, AMZN

Amazon.com

$764.72

5.36 (0.71%)

13:00
12/07/16
12/07
13:00
12/07/16
13:00
Hot Stocks
Impinj continues to advance after Amazon's checkout-free store concept »

Shares of Impinj (PI),…

PI

Impinj

$29.58

2.1 (7.64%)

AMZN

Amazon.com

$764.72

5.36 (0.71%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

F

Ford

$12.72

0.1599 (1.27%)

13:00
12/07/16
12/07
13:00
12/07/16
13:00
Options
Bullish yearend play opened in Ford options »

Bullish yearend play…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Jan

  • 10

    Jan

GNC

GNC Holdings

$14.10

-0.1 (-0.70%)

12:59
12/07/16
12/07
12:59
12/07/16
12:59
Hot Stocks
GNC Holdings comments on agreement with DOJ »

GNC Holdings issued the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

T

AT&T

$40.03

0.6844 (1.74%)

, TWX

Time Warner

$93.69

-0.206 (-0.22%)

12:55
12/07/16
12/07
12:55
12/07/16
12:55
Periodicals
AT&T CEO defends Time Warner deal at Senate hearing, FT says »

AT&T (T) chairman and…

T

AT&T

$40.03

0.6844 (1.74%)

TWX

Time Warner

$93.69

-0.206 (-0.22%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

  • 07

    Dec

  • 07

    Dec

SPY

SPDR S&P 500 ETF Trust

$222.42

0.72 (0.32%)

, SPX

S&P 500

$2,219.24

7.01 (0.32%)

12:55
12/07/16
12/07
12:55
12/07/16
12:55
Technical Analysis
S&P 500 breaks to fresh life high »

The index was last at…

SPY

SPDR S&P 500 ETF Trust

$222.42

0.72 (0.32%)

SPX

S&P 500

$2,219.24

7.01 (0.32%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FTK

Flotek

$10.58

-2.53 (-19.30%)

12:51
12/07/16
12/07
12:51
12/07/16
12:51
Hot Stocks
FourWorld says Flotek overstates impact of CnF on well productivity »

FourWorld Capital…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

  • 07

    Dec

AON

Aon plc

$114.10

0.89 (0.79%)

, MS

Morgan Stanley

$42.46

-0.05 (-0.12%)

12:47
12/07/16
12/07
12:47
12/07/16
12:47
Periodicals
Aon exploring sale of benefits outsourcing division, Reuters reports »

Aon (AON) is looking into…

AON

Aon plc

$114.10

0.89 (0.79%)

MS

Morgan Stanley

$42.46

-0.05 (-0.12%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NUE

Nucor

$66.42

0.835 (1.27%)

12:45
12/07/16
12/07
12:45
12/07/16
12:45
Options
Nucor call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.